our best estimate as to future market demands, and harvest and sell them when market conditions are favorable. We anticipate that we will continue doing so in upcoming fiscal year, but do not expect a significant increase from fiscal 2013 in terms of revenue or gross profit.Quarterly Revenue by Segment
The following table breaks down the revenue for our three business segments for the three months ended June 30, 2013 and 2012:Three months ended June 30,20132012Amount% of total
revenueAmount% of total
changeRevenue from retail businessRevenue from drugstores$
1,255,12015.0%Revenue from online sales1,264,1728.2%561,3581.7%702,814125.2%Sub-total of retail revenue10,912,39071.1%8,954,45627.3%1,957,93421.9%Revenue from wholesale business4,424,12928.8%21,368,78365.0%(16,944,654)(79.3)%Revenue from farming business--%2,524,0917.7%(2,524,091)(100.0)%Total revenue$
(17,510,811)(53.3)%The revenue fluctuation period over period reflected the following:
Drugstore revenue increased by approximately $1.2 million or 15% period over period, primarily due to three factors. First, we reconfigured operating strategy to refocus on our strengths.
For example, by hiring additional doctors for our clinics, we were able to attract and serve more patients who in turn purchased their medication from our stores.
Second, all of the stores that we opened in Hangzhou during the past two years are now able to accept state-sponsored medical insurance, six of which were unable to do so a year ago.
Since insurance reimbursement accounted for approximately 50% our drugstore revenue from Hangzhou in the past year, the ability to accept medical insurance is a significant factor in a store's operating performance.
Third, the modest growth in Chinese economy has encouraged consumers to
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine technology :1
|SOURCE China Jo-Jo Drugstores, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs2
. CentraState and Freehold Radiology Group train physicians from China3
. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.4
. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report5
. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)6
. China Biologic Products Reports Higher Results for the First Quarter 20127
. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results8
. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)9
. China Botanic Attends 67th PHARMCHINA Fair10
. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory11
. China Botanic Attends the 111th China Import and Export Fair